Abstract
Survival curves for 173 patients with pathologic Stage I and II bronchial carcinoma were calculated. These curves demonstrated far too much heterogeneity in patients with pathological Stage I disease. We recommend that the American Joint Committee Staging System be modified so that patients with T1N0 tumors are classified as Stage I disease and patients with T1N1, T1N0 and T2N1 tumors are classified as Stage II disease.
Cite
CITATION STYLE
APA
Lillimoe, K., Lipford, E., Eggleston, J. C., & Baker, R. R. (1984). Staging of bronchial carcinoma. Surgery Gynecology and Obstetrics, 158(6), 566–568. https://doi.org/10.1007/978-3-540-68879-2_42
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free